日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma progressing after molecular targeted therapy: A multicenter prospective observational study

阿特珠单抗联合贝伐珠单抗治疗分子靶向治疗后进展的不可切除肝细胞癌：一项多中心前瞻性观察研究

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000030871
Sugimoto, Rie; Satoh, Takeaki; Ueda, Akihiro; Senju, Takeshi; Tanaka, Yuki; Yamashita, Shinsaku; Koyanagi, Toshimasa; Kurashige, Tomoyuki; Higuchi, Nobito; Nakamura, Tsukasa; Tanaka, Masatake; Azuma, Yuuki; Ohno, Akari; Ooho, Aritsune; Ooe, Mari; Mutsuki, Taiji; Uchimura, Koutarou; Kuniyoshi, Masami; Tada, Seiya; Aratake, Yoshifusa; Yoshimoto, Tsuyoshi; Yamashita, Naoki; Harada, Shigeru; Nakamuta, Makoto; Motomura, Kenta; Kohjima, Motoyuki
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Factors Contributing to the Prognosis after Second-line Therapy with Ramucirumab in Advanced Hepatocellular Carcinoma

影响晚期肝细胞癌二线雷莫芦单抗治疗后预后的因素

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.9237-21
Sugimoto, Rie; Motomura, Kenta; Ooho, Aritsune; Aratake, Yoshifusa; Ueda, Akihiro; Senju, Takeshi; Tanaka, Yuki; Yada, Masayoshi; Tanaka, Kohsuke; Kuwano, Akifumi; Morita, Yuusuke; Nagasawa, Shigehiro; Ooe, Mari; Mutsuki, Taiji; Yoshimoto, Tsuyoshi; Yamashita, Naoki; Nakashima, Mai; Hioki, Tomonobu; Koyanagi, Toshimasa; Higuchi, Nobito; Nakamura, Tsukasa; Harada, Shigeru; Tanaka, Masatake; Tada, Seiya; Satoh, Takeaki; Uchimura, Koutarou; Kuniyoshi, Masami; Nakamuta, Makoto; Kohjima, Motoyuki
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Effects of insulin resistance and hepatic lipid accumulation on hepatic mRNA expression levels of apoB, MTP and L-FABP in non-alcoholic fatty liver disease

胰岛素抵抗和肝脏脂质蓄积对非酒精性脂肪性肝病中肝脏载脂蛋白B、MTP和L-FABP mRNA表达水平的影响

期刊:Experimental and Therapeutic Medicine
影响因子:2.3
doi:10.3892/etm.2011.328
Higuchi, Nobito; Kato, Masaki; Tanaka, Masatake; Miyazaki, Masayuki; Takao, Shinichiro; Kohjima, Motoyuki; Kotoh, Kazuhiro; Enjoji, Munechika; Nakamuta, Makoto; Takayanagi, Ryoichi
代谢
MTP
脂肪肝
免疫/内分泌
发表日期：2011
文献求助 收藏

The state of cholesterol metabolism in the liver of patients with primary biliary cirrhosis: the role of MDR3 expression

原发性胆汁性肝硬化患者肝脏胆固醇代谢状态：MDR3表达的作用

期刊:Hepatology International
影响因子:6.1
doi:10.1007/s12072-009-9137-y
Enjoji, Munechika; Yada, Ryoko; Fujino, Tatsuya; Yoshimoto, Tsuyoshi; Yada, Masayoshi; Harada, Naohiko; Higuchi, Nobito; Kato, Masaki; Kohjima, Motoyuki; Taketomi, Akinobu; Maehara, Yoshihiko; Nakashima, Manabu; Kotoh, Kazuhiro; Nakamuta, Makoto
肝硬化
代谢
发表日期：2009
文献求助 收藏

NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells

NIM811是一种非免疫抑制性的环孢素类似物，它能抑制肝星状细胞中胶原蛋白的生成并增强胶原酶的活性。

期刊:Liver International
影响因子:5.2
doi:10.1111/j.1478-3231.2007.01560.x
Kohjima, Motoyuki; Enjoji, Munechika; Higuchi, Nobito; Kotoh, Kazuhiro; Kato, Masaki; Takayanagi, Ryoiichi; Nakamuta, Makoto
细胞生物学
免疫/内分泌
发表日期：2007
文献求助 收藏